Home
>
US Stocks
>
PDS Biotechnology Corporation
PDS Biotechnology Corporation
PDSB

PDS Biotechnology Corporation (PDSB)

$11.6715.98%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
11.11
Today Low/High
11.11 / 11.72
52 Week Low/High
$1.84 / $13.48
Market Cap
$281.4M

Company Details

PDS Biotech is a clinical-stage immunotherapy company with a growing pipeline of cancer immunotherapies and infectious disease vaccines based on the Company's proprietary Versamune® T-cell activating technology platform. Versamune® effectively delivers disease-specific antigens for in vivo uptake and processing, while also activating the critical type 1 interferon immunological pathway, resulting in production of potent disease-specific killer T-cells as well as neutralizing antibodies. PDS Biotech has engineered multiple therapies, based on combinations of Versamune® and disease-specific antigens, designed to train the immune system to better recognize disease cells and effectively attack and destroy them.
Organisation
PDS Biotechnology Corporation
Headquaters
Florham Park, New Jersey, United States
Employees
15
Industry
Biotechnology
CEO
Frank Bedu-Addo

Discover more

Frequently Asked Questions

What is PDS Biotechnology Corporation (PDSB) share price today?

Can Indians buy PDS Biotechnology Corporation (PDSB) shares?

How can I buy PDS Biotechnology Corporation (PDSB) shares from India?

Can Fractional shares of PDS Biotechnology Corporation (PDSB) be purchased?

What are the documents required to start investing in PDS Biotechnology Corporation (PDSB) stocks?

We are a SEBI registered investement advisor